Hair cloning and future treatments: what is real today
Headlines about hair cloning and lab-grown follicles appear every year. Here is what is actually available now, what is still in research, and how to spot claims that run ahead of the science.
Every few months a news story promises that hair loss will soon be "solved" by cloning, stem cells or a new injection. Research in this area is real and active. But there is a large gap between a promising laboratory finding and a safe, proven treatment you can get at a clinic. This guide separates what is available today from what is still being studied.
What "hair cloning" means
Hair cloning usually refers to taking a small number of a person's own follicle cells, multiplying them in a laboratory, and putting them back into the scalp to form many new follicles. The idea is attractive because hair transplants are limited by the number of follicles in the donor area at the back and sides of the head.
A 2025 review of the state of hair transplant surgery listed hair follicle cloning as a future direction, alongside artificial intelligence, better instruments and improved medical treatment used together with surgery 1. In other words, it is not a standard treatment today.
Why cloning is difficult
A hair follicle is a complex mini-organ. It needs the right mix of cells, signals and blood supply to form, cycle through growth and rest, and produce a hair that grows at the right angle, colour and thickness. Reviews of stem cell approaches for pattern hair loss describe both conventional and newer cell-based strategies and the challenges in turning them into reliable treatments 2. Key questions include:
- Can cultured cells keep their hair-forming ability after they are multiplied?
- Will new follicles grow in a natural direction and pattern?
- Are the results long-lasting and safe, including over many years?
- Can it be done at a reasonable cost and quality?
Until these are answered in well-designed human trials, cloning remains research.
Stem cell and "regenerative" treatments today
Some clinics already offer treatments described as stem cell, growth factor or regenerative therapies. These are not the same as cloning. A 2023 systematic review of stem cell-based treatments for hair loss included 14 articles and described the results as promising, with no major side effects reported, but advised caution because the studies were small and varied in method 3. See stem cell treatments for hair loss.
Exosomes
Exosomes are tiny particles released by cells, and they are being marketed for hair. A 2024 systematic review found only 9 studies with 125 patients, and noted at least 10 serious adverse events in the wider literature on these products 4. Many products are not approved for this use. See exosomes for hair loss.
What is genuinely new and available
Some newer treatments have moved from research to approved use after large trials:
- JAK inhibitors for severe alopecia areata. Baricitinib and ritlecitinib were tested in large randomised trials and are now approved in several countries for severe alopecia areata 5 6. They are not treatments for pattern hair loss. See JAK inhibitors for alopecia areata.
- Refinements in hair transplant surgery. Better instruments, hairline design and combined medical treatment have improved results 1.
- New ways of using older medicines, such as low-dose oral minoxidil and topical finasteride, which are now discussed in expert guidance (see topical finasteride).
How to judge a "breakthrough" headline
Ask these questions:
- Was it tested in people? Many reports describe results in cells or mice.
- How many people, and was there a comparison group? Small studies without a control group can be misleading.
- Was it published in a peer-reviewed journal? Press releases are not the same as published evidence.
- Is it approved for hair loss where you live? If not, it may only be available through clinical trials.
- Who is selling it? Be cautious if a clinic charges high fees for an experimental treatment outside a trial.
- What are the risks? New does not mean safe.
What to do now
If you are losing hair, waiting for a future treatment can mean losing more hair in the meantime. Proven options already exist for many causes. For pattern hair loss, these include minoxidil and, for men, finasteride, which have the strongest evidence 7. Early assessment helps you choose. See an evidence-based overview of male pattern hair loss treatment and combining hair loss treatments.
If you are interested in research treatments, ask a dermatologist whether any registered clinical trials are suitable for you, rather than paying for unproven procedures.
The bottom line
Hair cloning and lab-grown follicles are an exciting area of research, but they are not a standard treatment today. Some regenerative treatments are offered now, yet their evidence is limited. Meanwhile, there are proven options that work for many people. Be curious about the future, but base today's decisions on today's evidence. See also treatments with weak evidence.
Frequently asked questions
Is hair cloning available now?
No. A 2025 review lists hair follicle cloning as a future direction, not a current standard treatment 1.
Are stem cell treatments for hair proven?
A 2023 review of 14 articles found promising results but advised caution because studies were small and varied 3.
Are exosomes safe for hair loss?
Evidence is limited: 9 studies with 125 patients, and at least 10 serious adverse events reported in the wider literature 4.
Should I wait for new treatments?
Waiting can mean more hair loss. Proven options exist for many causes, so it is worth getting assessed now 7.
Sources
- PubMed. Hair Transplantation: State of the Art, Dermatol Surg, 2025. accessed 27 Oct 2026
- PubMed. Conventional and novel stem cell based therapies for androgenic alopecia, Stem Cells Cloning, 2017. accessed 27 Oct 2026
- PubMed. Human Stem Cell Use in Androgenetic Alopecia: A Systematic Review, Cells, 2023. accessed 27 Oct 2026
- PubMed. Exosomes for Treating Hair Loss: A Review of Clinical Studies, Dermatol Surg, 2025. accessed 27 Oct 2026
- PubMed. Two Phase 3 Trials of Baricitinib for Alopecia Areata, N Engl J Med, 2022. accessed 27 Oct 2026
- PubMed. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial, Lancet, 2023. accessed 27 Oct 2026
- PubMed. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis, J Am Acad Dermatol, 2017. accessed 27 Oct 2026
Educational content. Not medical advice.